Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

American Medical Association’s digital advisors table RPM coding reform proposal, again

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

February 15, 2024

Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy – Pharmaceutical Technology

ANS-858 is an investigational selective and reversible ALDH2 inhibitor, which has been reported to reduce craving and drug-seeking behaviour in preclinical studies. Image Credit: Axel

August 2, 2023

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), using an automated deep-learning AI tool, as well as weight-based volumetric

July 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.